Fintel on MSN16d
Baird Upgrades McKesson (MCK)Fintel reports that on November 7, 2024, Baird upgraded their outlook for McKesson (NYSE:MCK) from Neutral to Outperform. ...
The pharmaceutical distributor has launched InspiroGene, a business unit offering logistics and other support for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback